AI Verdict
RGS has stronger fundamentals based on our AI analysis.
RGS vs RGPX Fundamental Comparison
| Metric | RGS | RGPX |
|---|---|---|
| Revenue | $116.1M | $1,775.0 |
| Net Income | $1.8M | $-1.5M |
| Net Margin | 1.6% | -83,244.8% |
| ROE | 1.0% | N/A |
| ROA | 0.3% | -239.2% |
| Current Ratio | 0.53x | 0.01x |
| Debt/Equity | 0.60x | N/A |
| EPS | $0.64 | N/A |
Green = Better metric | Red = Weaker metric
You Might Also Compare
RGS vs RGPX: Frequently Asked Questions
Is RGS or RGPX a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), RGS has stronger fundamentals. RGS is rated SELL (68% confidence) while RGPX is rated STRONG SELL (98% confidence). This is not investment advice.
How does RGS compare to RGPX fundamentally?
REGIS CORP has ROE of 1.0% vs REGENEREX PHARMA, INC.'s N/A. Net margins are 1.6% vs -83,244.8% respectively.
Which stock pays higher dividends, RGS or RGPX?
RGS has a dividend yield of N/A or no dividend while RGPX has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in RGS or RGPX for long term?
For long-term investing, consider that RGS has SELL rating with 68% confidence, while RGPX has STRONG SELL rating with 98% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about RGS vs RGPX?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For RGS vs RGPX, the AI consensus favors RGS based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.